AMH levels at central precocious puberty and premature thelarche: is it a parameter?
The possible difference of antimüllerian hormone (AMH) levels at central precocious puberty (CPP) and premature thelarche (PT) has not been properly evaluated. By evaluating AMH levels in girls with diagnosed CPP and PT, we aim to show the change of AMH levels at the pubertal onset. Sixty-five girls who have breast development before the age of 8 years and 25 healthy girls were enrolled in the study. The subjects were divided into two groups as CPP and PT, according to results of GnRH test. AMH levels were determined in the two groups. The mean AMH levels of the CPP group were significantly lower than those in the PT group (13.57±9.85 pmol/L and 58.42±12.78 pmol/L, respectively, p=0.022). These results suggest that the AMH levels decrease in the duration of the hypothalamus-pituitary-ovarian axis activation. We thought that AMH might/may be a marker for distinguishing between CPP and PT.